Novartis Ups Forecast on Lack of Diovan Competitor

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 17 (Bloomberg) -- Novartis AG raised its full-year forecast as generic competition for the Diovan blood-pressure drug failed to materialize in the U.S. Sam Fazeli reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change